Knock-in of human SIRPA into immunodeficient C57BL/6 recombination activating genes 1/2 (Rag1/2^null), interleukin-2 (IL-2) receptor common γ chain subunit (IL2rg^null) strain (BRGS) leads to enhanced human engraftment without inducing anemia/thrombocytopenia.